|
The PRONTO amyloidosis study: A randomized, double-blind, placebo-controlled, global, phase 2b study of NEOD001 in previously treated subjects with light chain amyloidosis and persistent cardiac dysfunction. |
|
|
|
Consulting or Advisory Role - GlaxoSmithKline; Millennium; Takeda |
Speakers' Bureau - Pfizer |
Travel, Accommodations, Expenses - Janssen |
|
|
Consulting or Advisory Role - Prothena |
Research Funding - Prothena |
|
|
|
Consulting or Advisory Role - Janssen; Takeda |
Research Funding - Amgen; Prothena; Takeda |
|
|
Consulting or Advisory Role - GlaxoSmithKline; Janssen; Prothena; Takeda |
Research Funding - Janssen; Karyopharm Therapeutics; Prothena; Takeda |
|
|
Research Funding - Celgene; Prothena; Takeda |
|
|
Consulting or Advisory Role - GlaxoSmithKline; Janssen; Takeda |
|
|
Consulting or Advisory Role - Array BioPharma; Bristol-Myers Squibb; Celgene; Prothena |
Research Funding - Celgene |
|
|
Honoraria - Celgene; Janssen |
Consulting or Advisory Role - Janssen |
Research Funding - Celgene; Janssen |
Travel, Accommodations, Expenses - Binding Site; Janssen; Medac |
|
|
|
Stock and Other Ownership Interests - Prothena |
|
|
No Relationships to Disclose |
|
|
|
Stock and Other Ownership Interests - Prothena |
Consulting or Advisory Role - Janssen |
|
|
|
|
Stock and Other Ownership Interests - Prothena |
Travel, Accommodations, Expenses - Prothena (I) |
|
|
Honoraria - Celgene; Isis Pharmaceuticals; Med Learning Group; Millennium; Novartis; Onyx; Prothena; Research to Practice; Sanofi |
Consulting or Advisory Role - Prothena |
Travel, Accommodations, Expenses - Celgene; Novartis; Prothena |